Latest options for treatment of bronchiolitis in infants

References

• Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–598.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118(4):1774–1793.
   PubMed Web of Science ®Google Scholar
• Hall CB, Weinberg GA, Blumkin AK, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132(2):e341–e348.
   PubMed Web of Science ®Google Scholar
• Bosis S, Esposito S, Niesters HG, et al. Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences. Clin Microbiol Infect. 2008;14(7):677–684.
   PubMed Web of Science ®Google Scholar
• Paranhos-Baccalà G, Komurian-Pradel F, Richard N, et al. Mixed respiratory virus infections. J Clin Virol. 2008;43(4):407–410.
   PubMed Web of Science ®Google Scholar
• Mansbach JM, Piedra PA, Teach SJ, et al.; MARC-30 Investigators. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med. 2012;166(8):700–706.
   PubMedGoogle Scholar
• Lenney W, Boner AL, Bont L, et al. Medicines used in respiratory diseases only seen in children. Eur Respir J. 2009;34(3):531–551.
   PubMed Web of Science ®Google Scholar
• Da Dalt L, Bressan S, Martinolli F, et al. Treatment of bronchiolitis: state of the art. Early Hum Dev. 2013;89 Suppl 1:S31–S36.
   PubMedGoogle Scholar
• Mazur NI, Martinón-Torres F, Baraldi E, et al.; Respiratory Syncytial Virus Network (ReSViNET). Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med. 2015;3(11):888–900.
   PubMed Web of Science ®Google Scholar
• Ochoa Sangrador C, González de Dios J; Research Group of the aBREVIADo Project. Overuse of bronchodilators and steroids in bronchiolitis of different severity: bronchiolitis-study of variability, appropriateness, and adequacy. Allergol Immunopathol (Madr). 2014;42(4):307–315.
   PubMed Web of Science ®Google Scholar
• Plint AC, Grenon R, Klassen TP, et al. Bronchodilator and steroid use for the management of bronchiolitis in Canadian pediatric emergency departments. CJEM. 2015;17(1):46–53.
   PubMedGoogle Scholar
• Scottish Intercollegiate Guidelines Network (SIGN). Bronchiolitis in children. Guideline no. 91. 2006. [cited 2016 Mar 1]. Available at http://www.sign.ac.uk/pdf/qrg91.pdf
   Google Scholar
• Bronchiolitis Guideline Team, Cincinnati Children’s Hospital Medical Center. Evidence based clinical practice guideline for medical management of bronchiolitis in infants 1 year of age or less presenting with a first time episode. Cincinnati: Cincinnati Children’s Hospital Medical Center; last revisioned November 2010.
   Google Scholar
• Ricci V, Delgado Nunes V, Murphy MS, et al.; Guideline Development Group and Technical Team. Bronchiolitis in children: summary of NICE guidance. BMJ. 2015;350:h2305.
   PubMed Web of Science ®Google Scholar
• Baraldi E, Lanari M, Manzoni P, et al. Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr. 2014;40:65.
   PubMed Web of Science ®Google Scholar
• Mittal V, Hall M, Morse R, et al. Impact of inpatient bronchiolitis clinical practice guideline implementation on testing and treatment. J Pediatr. 2014;165(3):570–576.e3.
   PubMed Web of Science ®Google Scholar
• Parikh K, Hall M, Mittal V, et al. Establishing benchmarks for the hospitalized care of children with asthma, bronchiolitis, and pneumonia. Pediatrics. 2014;134(3):555–562.
   PubMed Web of Science ®Google Scholar
• Akenroye AT, Baskin MN, Samnaliev M, et al. Impact of a bronchiolitis guideline on ED resource use and cost: a segmented time-series analysis. Pediatrics. 2014;133(1):e227–34.
   PubMed Web of Science ®Google Scholar
• Ralston S, Comick A, Nichols E, et al. Effectiveness of quality improvement in hospitalization for bronchiolitis: a systematic review. Pediatrics. 2014;134(3):571–581.
   PubMed Web of Science ®Google Scholar
• Ralston S, Garber M, Narang S, et al. Decreasing unnecessary utilization in acute bronchiolitis care: results from the value in inpatient pediatrics network. J Hosp Med. 2013;8(1):25–30.
   PubMed Web of Science ®Google Scholar
• Ralston S, Parikh K, Goodman D. Benchmarking overuse of medical interventions for bronchiolitis. JAMA Pediatr. 2015;169(9):805–806.
   PubMed Web of Science ®Google Scholar
• Umoren R, Odey F, Meremikwu MM. Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age. Cochrane Database Syst Rev. 2011;1:CD006435.
   PubMed Web of Science ®Google Scholar
• Jat KR, Mathew JL. Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. Cochrane Database Syst Rev. 2015;1:CD010473.
   PubMedGoogle Scholar
• Milési C, Baleine J, Matecki S, et al. Is treatment with a high flow nasal cannula effective in acute viral bronchiolitis? A physiologic study. Intensive Care Med. 2013;39(6):1088–1094.
   PubMed Web of Science ®Google Scholar
• Arora B, Mahajan P, Zidan MA, et al. Nasopharyngeal airway pressures in bronchiolitis patients treated with high-flow nasal cannula oxygen therapy. Pediatr Emerg Care. 2012;28(11):1179–1184.
   PubMed Web of Science ®Google Scholar
• Hilliard TN, Archer N, Laura H, et al. Pilot study of vapotherm oxygen delivery in moderately severe bronchiolitis. Arch Dis Child. 2012;97(2):182–183.
   PubMed Web of Science ®Google Scholar
• Bressan S, Balzani M, Krauss B, et al. High-flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study. Eur J Pediatr. 2013;172:1649–1656.
   PubMed Web of Science ®Google Scholar
• Riese J, Fierce J, Riese A, et al. Effect of a hospital-wide high-flow nasal cannula protocol on clinical outcomes and resource utilization of bronchiolitis patients admitted to the PICU. Hosp Pediatr. 2015;5(12):613–618.
   PubMedGoogle Scholar
• Sinha IP, McBride AKS, Smith R, et al. CPAP and high-flow nasal cannula oxygen in bronchiolitis. Chest. 2015;148(3):810–823.
   PubMed Web of Science ®Google Scholar
• Wegner AA, Cespedes FP, Godoy MML, et al. [High flow nasal cannula in infants: Experience in a critical patient unit]. Rev Chil Pediatr. 2015;86(3):173–181.
   PubMedGoogle Scholar
• Wraight TI, Ganu SS. High-flow nasal cannula use in a paediatric intensive care unit over 3 years. Crit Care Resusc. 2015;17(3):197–201.
   PubMed Web of Science ®Google Scholar
• Long E, Babl FE, Duke T. Is there a role for humidified heated high-flow nasal cannula therapy in paediatric emergency departments? Emerg Med J. 2016.
   Google Scholar
• Franklin D, Dalziel S, Schlapbach LJ, et al.; PARIS and PREDICT. Early high flow nasal cannula therapy in bronchiolitis, a prospective randomised control trial (protocol): A paediatric acute respiratory intervention study (PARIS). BMC Pediatr. 2015;15(1):183.
   PubMed Web of Science ®Google Scholar
• Liet JM, Ducruet T, Gupta V, et al. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database Syst Rev. 2015;9:CD006915.
   PubMedGoogle Scholar
• Zhang L, Mendoza-Sassi RA, Wainwright C, et al. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2013;7:CD006458.
   PubMed Web of Science ®Google Scholar
• Morawetz D, Cheah E, Barton R, et al. Is nebulised hypertonic saline useful as an adjunctive treatment for acute bronchiolitis in infants and children less than 24 months of age? J Paediatr Child Health. 2011;47(12):922–926.
   PubMed Web of Science ®Google Scholar
• Ralston S. Repeated dosing of nebulised 5% saline improves respiratory scores in inpatients with mild to moderate bronchiolitis at 48 h. Evid Based Med. 2011;16(3):82–83.
   PubMedGoogle Scholar
• Kuzik BA, Al-Qadhi SA, Kent S, et al. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr. 2007;151(3):266–270, 270.e1.
   PubMed Web of Science ®Google Scholar
• Mandelberg A, Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatr Pulmonol. 2010;45(1):36–40.
   PubMed Web of Science ®Google Scholar
• Ralston S, Hill V, Martinez M. Nebulized hypertonic saline without adjunctive bronchodilators for children with bronchiolitis. Pediatrics. 2010;126(3):e520–e525.
   PubMed Web of Science ®Google Scholar
• Wu S, Baker C, Lang ME, et al. Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial. JAMA Pediatr. 2014;168(7):657–663.
   PubMed Web of Science ®Google Scholar
• Faber TE, Kamps AW, Sjoerdsma MH, et al. Computerized assessment of wheezing in children with respiratory syncytial virus bronchiolitis before and after hypertonic saline nebulization. Respir Care. 2015;60(9):1252–1256.
   PubMed Web of Science ®Google Scholar
• Teunissen J, Hochs AH, Vaessen-Verberne A, et al. The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial. Eur Respir J. 2014;44(4):913–921.
   PubMed Web of Science ®Google Scholar
• Florin TA, Byczkowski T, Ruddy RM, et al. Utilization of nebulized 3% saline in infants hospitalized with bronchiolitis. J Pediatr. 2015;166(5):1168–1174.e2.
   PubMed Web of Science ®Google Scholar
• Florin TA, Shaw KN, Kittick M, et al. Nebulized hypertonic saline for bronchiolitis in the emergency department: a randomized clinical trial. JAMA Pediatr. 2014;168(7):664–670.
   PubMed Web of Science ®Google Scholar
• Everard ML, Hind D, Ugonna K, et al. Saline in Acute Bronchiolitis RCT and Economic evaluation: hypertonic saline in acute bronchiolitis - randomised controlled trial and systematic review. Health Technol Assess. 2015;19(66):1–130.
   Web of Science ®Google Scholar
• Everard ML, Hind D, Ugonna K, et al.; SABRE Study Team. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Thorax 2014;69(12):1105–1112.
   PubMed Web of Science ®Google Scholar
• Barben J, Kuehni CE. Hypertonic saline for acute viral bronchiolitis: take the evidence with a grain of salt. Eur Respir J. 2014;44(4):827–830.
   PubMed Web of Science ®Google Scholar
• Legg JP, Cunningham S. Hypertonic saline for bronchiolitis: a case of less is more. Arch Dis Child. 2015 Dec;100(12):1104–1105.
   PubMed Web of Science ®Google Scholar
• Gadomski AM, Brower M. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2010;12:CD001266.
   PubMed Web of Science ®Google Scholar
• Hartling L, Bialy LM, Vandermeer B, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2011;6:CD003123.
   PubMed Web of Science ®Google Scholar
• Flores P, Mendes AL, Neto AS. A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants. Pediatr Pulmonol. 2015.
   PubMedGoogle Scholar
• Flores G, Horwitz RI. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics. 1997;100(2 Pt 1):233–239.
   PubMed Web of Science ®Google Scholar
• Kellner JD, Ohlsson A, Gadomski AM, et al. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2000;2:CD001266. Review. Update in: Cochrane Database Syst Rev. 2006;(3): CD001266
   PubMedGoogle Scholar
• Kellner JD, Ohlsson A, Gadomski AM, et al. Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. Arch Pediatr Adolesc Med. 1996;150(11):1166–1172.
   PubMedGoogle Scholar
• Management of Bronchiolitis in Infants, The Hospital for Sick Children. Clinical practice guideline, Last Modified: 2011 Nov 8.
   Google Scholar
• Morgan SE, Mosakowski S, Solano P, et al. High-flow nasal cannula and aerosolized β agonists for rescue therapy in children with bronchiolitis: a case series. Respir Care. 2015;60(9):e161–e165.
   PubMed Web of Science ®Google Scholar
• Zorc JJ. Inhaled epinephrine does not shorten hospital stay for infants with bronchiolitis destined to develop repeated bronchospasm. Lancet Respir Med. 2015;3(9):665–667.
   PubMed Web of Science ®Google Scholar
• Skjerven HO, Hunderi JOG, Brügmann-Pieper SK, et al. Racemic adrenaline and inhalation strategies in acute bronchiolitis. N Engl J Med. 2013;368(24):2286–2293.
   PubMed Web of Science ®Google Scholar
• Skjerven HO, Rolfsjord LB, Berents TL, et al. Allergic diseases and the effect of inhaled epinephrine in children with acute bronchiolitis: follow-up from the randomised, controlled, double-blind, Bronchiolitis ALL trial. Lancet Respir Med. 2015;3(9):702–708.
   PubMed Web of Science ®Google Scholar
• Blom D, Ermers M, Bont L, et al. Inhaled corticosteroids during acute bronchiolitis in the prevention of post bronchiolitic wheezing. Cochrane Database Syst Rev. 2007;1:CD004881. Review. Update in: Cochrane Database Syst Rev.2011;(1): CD004881.
   PubMed Web of Science ®Google Scholar
• Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013;6:CD004878.
   PubMed Web of Science ®Google Scholar
• Corneli HM, Zorc JJ, Mahajan P, et al.; Bronchiolitis Study Group of the Pediatric Emergency Care Applied Research Network (PECARN). A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007;357(4):331–339.
   PubMed Web of Science ®Google Scholar
• Zomer-Kooijker K, van der Ent CK, Ermers MJJ, et al.; RSV Corticosteroid Study Group. Lack of long-term effects of high-dose inhaled beclomethasone for respiratory syncytial virus bronchiolitis: a randomized placebo-controlled trial. Pediatr Infect Dis J. 2014;33(1):19–23.
   PubMed Web of Science ®Google Scholar
• Beigelman A, Chipps BE, Bacharier LB. Update on the utility of corticosteroids in acute pediatric respiratory disorders. Allergy Asthma Proc. 2015;36(5):332–338.
   PubMed Web of Science ®Google Scholar
• Jartti T, Lehtinen P, Vuorinen T, et al. Bronchiolitis: age and previous wheezing episodes are linked to viral etiology and atopic characteristics. Pediatr Infect Dis J. 2009;28(4):311–317.
   PubMed Web of Science ®Google Scholar
• Plint AC, Johnson DW, Patel H, et al.; Pediatric Emergency Research Canada (PERC). Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med. 2009;360(20):2079–2089.
   PubMed Web of Science ®Google Scholar
• Spurling GK, Doust J, Del Mar CB, et al. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev. 2011;6:CD005189.
   PubMed Web of Science ®Google Scholar
• Kourlaba G, Kourkouni E, Spyridis N, et al. Antibiotic prescribing and expenditures in outpatient paediatrics in Greece, 2010-13. J Antimicrob Chemother. 2015;70(8):2405–2408.
   PubMed Web of Science ®Google Scholar
• Guzmán Molina C, Rodríguez-Belvís MV, Coroleu Bonet A, et al. Antibiotics in respiratory tract infections in hospital pediatric emergency departments. Arch Bronconeumol. 2014;50(9):375–378.
   PubMed Web of Science ®Google Scholar
• Farley R, Spurling GK, Eriksson L, et al. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev. 2014;10:CD005189.
   PubMed Web of Science ®Google Scholar
• Ventre K, Randolph A. WITHDRAWN: ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev. 2010;5:CD000181.
   PubMedGoogle Scholar
• Mooney K, Melvin M, Douglas T. Ribavirin: the need for exposure precautions. Clin J Oncol Nurs. 2014;18(5):E93–6.
   PubMed Web of Science ®Google Scholar
• Li L, Avery R, Budev M, et al. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant. 2012;31(8):839–844.
   PubMed Web of Science ®Google Scholar
• Burrows FS, Carlos LM, Benzimra M, et al. Oral ribavirin for respiratory syncytial virus infection after lung transplantation: efficacy and cost-efficiency. J Heart Lung Transplant. 2015;34(7):958–962.
   PubMed Web of Science ®Google Scholar
• Edell D, Khoshoo V, Ross G, et al. Early ribavarin treatment of bronchiolitis: effect on long-term respiratory morbidity. Chest. 2002;122(3):935–939.
   PubMed Web of Science ®Google Scholar
• Livni G, Rachmel A, Marom D, et al. A randomized,double-blind study examining the comparative efficacies and safety of inhaled epinephrine and nasal decongestant in hospitalized infants with acute bronchiolitis. Pediatr Infect Dis J. 2010;29(1):71–73.
   PubMed Web of Science ®Google Scholar
• Ralston S, Roohi M. A randomized, controlled trial of nasal phenylephrine in infants hospitalized for bronchiolitis. J Pediatr. 2008;153(6):795–798.
   PubMed Web of Science ®Google Scholar
• Naz F, Raza AB, Ijaz I, et al. Effectiveness of nebulized N-acetylcysteine solution in children with acute bronchiolitis. J Coll Physicians Surg Pak. 2014;24(6):408–411.
   PubMed Web of Science ®Google Scholar
• Zedan M, Gamil N, El-Assmy M, et al. Montelukast as an episodic modifier for acute viral bronchiolitis: a randomized trial. Allergy Asthma Proc. 2010;31(2):147–153.
   PubMed Web of Science ®Google Scholar
• Amirav I, Luder AS, Kruger N, et al. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis. Pediatrics. 2008;122(6):e1249–e1255.
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Flores-Nunez A, Goh A, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med. 2008;178(8):854–860.
   PubMed Web of Science ®Google Scholar
• Bisgaard H; Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med. 2003;167(3):379–383.
   PubMed Web of Science ®Google Scholar
• Proesmans M, Sauer K, Govaere E, et al. Montelukast does not prevent reactive airway disease in young children hospitalized for RSV bronchiolitis. Acta Paediatr. 2009;98(11):1830–1834.
   PubMed Web of Science ®Google Scholar
• Kim CK, Choi J, Kim HB, et al. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation. J Pediatr. 2010;156(5):749–754.
   PubMed Web of Science ®Google Scholar
• Peng WS, Chen X, Yang XY, et al. Systematic review of montelukast’s efficacy for preventing post-bronchiolitis wheezing. Pediatr Allergy Immunol. 2014;25(2):143–150.
   PubMed Web of Science ®Google Scholar
• Liu F, Ouyang J, Sharma AN, et al. Leukotriene inhibitors for bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2015;3:CD010636.
   PubMedGoogle Scholar
• Enriquez A, Chu IW, Mellis C, et al. Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months. Cochrane Database Syst Rev. 2012;11:CD008395.
   PubMedGoogle Scholar
• Jat KR, Chawla D. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst Rev. 2015;8:CD009194.
   PubMedGoogle Scholar
• Sáez-Llorens X, Moreno MT, Ramilo O, et al.; MEDI-493 Study Group. Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection. Pediatr Infect Dis J. 2004;23(8):707–712.
   PubMed Web of Science ®Google Scholar
• Fuller HL, Del Mar CB. WITHDRAWN: immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database Syst Rev. 2010;9:CD004883.
   PubMed Web of Science ®Google Scholar
• McLellan JS, Chen M, Leung S, et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science. 2013;340(6136):1113–1117.
   PubMed Web of Science ®Google Scholar
• DeVincenzo JP, Whitley RJ, Mackman RL, et al. Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med. 2014;371(8):711–722.
   PubMed Web of Science ®Google Scholar
• DeVincenzo JP, McClure MW, Symons JA, et al. Activity of oral ALS-008176 in a respiratory syncytial virus challenge study. N Engl J Med. 2015;373(21):2048–2058.
   PubMed Web of Science ®Google Scholar
• Tayyari F, Marchant D, Moraes TJ, et al. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med. 2011;17(9):1132–1135.
   PubMed Web of Science ®Google Scholar
• Hegele RG, Mastrangelo P, Moraes T. Guanosine-rich oligonucleotide (gro) compostions, methods and uses for treating respiratory syncytial virus infection: WO 2013131182 A1 [cited 2014 Dec 8]. Available from: http://www.google.com/patents/WO2013131182A1?cl=en
   Google Scholar
• Pinto LA, Pitrez PM, Luisi F, et al. Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: arandomized, double-blinded, and placebo-controlled clinical trial. J Pediatr. 2012;161(6):1104–1108.
   PubMed Web of Science ®Google Scholar
• Beigelman A, Mikols CL, Gunsten SP, et al. Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis. Respir Res. 2010;11:90.
   PubMed Web of Science ®Google Scholar
• Beigelman A, Isaacson-Schmid M, Sajol G, et al. Randomized trial to evaluate azithromycin’s effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol. 2015;135(5):1171–1178.
   PubMed Web of Science ®Google Scholar
• O’Donnell K, Mansbach JM, LoVecchio F, et al.; Multicenter Airway Research Collaboration (MARC)-25; MARC-30 investigators. Use of cough and cold medications in severe bronchiolitis before and after a health advisory warning against their use. J Pediatr 2015;167(1):196–198.e1-2.
   PubMed Web of Science ®Google Scholar
• Safety review update of codeine use in children; new Boxed Warning and Contraindication on use after tonsillectomy and/or adenoidectomy. FDA Drug Safety Communication; [cited 2016 Jan 28]. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm339112.htm
   Google Scholar
• Codeine-containing medicinal products for the treatment of cough or cold in paediatric patients. European Medicine Agency [cited 2016 Jan 28]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Codeine_containing_medicinal_products_for_the_treatment_of_cough_and_cold_in_paediatric_patients/human_referral_prac_000039.jsp&mid=WC0b01ac05805c516f
   Google Scholar
• Ralston S, Hill V. Incidence of apnea in infants hospitalized with respiratory syncytial virus bronchiolitis: a systematic review. J Pediatr. 2009;155(5):728–733.
   PubMed Web of Science ®Google Scholar
• Turner A, Shann F, Delzoppo C, et al. A multicentre, randomised, double-blind, placebo-controlled trial of aminophylline for bronchiolitis in infants admitted to intensive care. Crit Care Resusc. 2014;16(3):220–224.
   PubMed Web of Science ®Google Scholar
• Acosta PL, Caballero MT, Polack FP. Brief history and characterization of enhanced respiratory syncytial virus disease. Clin Vaccine Immunol. 2015.
   PubMedGoogle Scholar
• Neuzil KM. Progress toward a Respiratory Syncytial Virus Vaccine. Clin Vaccine Immunol. 2016.
   PubMedGoogle Scholar
• Green CA, Scarselli E, Voysey M, et al. Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults. BMJ Open. 2015;5(10):e008748.
   PubMed Web of Science ®Google Scholar
• López-Sagaseta J, Malito E, Rappuoli R, et al. Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J. 2016;14:58–68.
   PubMed Web of Science ®Google Scholar
• Correia BE, Bates JT, Loomis RJ, et al. Proof of principle for epitope-focused vaccine design. Nature. 2014;507(7491):201–206.
   PubMed Web of Science ®Google Scholar